Corporate social responsibility to improve access to medicines: the case of Brazil

BACKGROUND: Access to medicines and the development of a strong national pharmaceutical industry are two longstanding pillars of health policy in Brazil. This is reflected in a clear emphasis by Brazil’s Federal Government on improving access to medicine in national health plans and industrial polic...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorsteinsdóttir, Halla, Ovtcharenko, Natasha, Kohler, Jillian Clare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320638/
https://www.ncbi.nlm.nih.gov/pubmed/28222793
http://dx.doi.org/10.1186/s12992-017-0235-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320638/
https://www.ncbi.nlm.nih.gov/pubmed/28222793
http://dx.doi.org/10.1186/s12992-017-0235-7

Ejemplares similares